In search of an optimum dose escalation for narrowband UVB phototherapy: is it time to quit 20% increments? Our aim was to compare 20% with 10% to 5% incremental regimens in narrowband UVB phototherapy.

Type:Uv phototherapy   Time:2015-01-08 23:09:00
In search of an optimum dose escalation for narrowband UVB phototherapy: is it time to quit 20% increments?
Our aim was to compare 20% with 10% to 5% incremental regimens in narrowband UVB phototherapy.
STUDY PATIENTS:
The study included patients with psoriasis (N = 191) with Fitzpatrick skin phototypes II and III.
RESULTS:
Occurrence of erythema as well as maximum and cumulative doses were higher with 20% escalations, whereas response rates and time to response did not significantly differ.
LIMITATIONS:
The study was limited by its retrospective nature.
CONCLUSION:
A 5% or 10% incremental regimen may have similar therapeutic efficacy.
Boztepe G1, Akinci H, Sahin S, Karaduman A, Evans SE, Erkin G, Atakan N, Akan T, Kölemen F.
www.kerneluvb.com----The leader manufacturer of UV Phototherapy.